NEI
Northwest & Ethical Investments Portfolio holdings
AUM $4.03B
1-Year Return
20.27%
This Quarter Return
+3.04%
1 Year Return
+20.27%
3 Year Return
+68.59%
5 Year Return
+133.3%
10 Year Return
+253.02%
AUM
$1.51B
AUM Growth
+$20.6M
(+1.4%)
Cap. Flow
-$9.04M
Cap. Flow
% of AUM
-0.6%
Top 10 Holdings %
Top 10 Hldgs %
20.29%
Holding
389
New
37
Increased
141
Reduced
136
Closed
32
Top Buys
| 1 |
EOG Resources
EOG
|
+$4.29M |
| 2 |
Adobe
ADBE
|
+$3.59M |
| 3 |
Salesforce
CRM
|
+$3.54M |
| 4 |
Waste Management
WM
|
+$3.42M |
| 5 |
Nice
NICE
|
+$3.35M |
Top Sells
| 1 |
RB Global
RBA
|
+$12.3M |
| 2 |
Aptiv
APTV
|
+$10.7M |
| 3 |
UFS
DOMTAR CORPORATION (New)
UFS
|
+$6.77M |
| 4 |
American Water Works
AWK
|
+$4.73M |
| 5 |
Lockheed Martin
LMT
|
+$3.79M |
Sector Composition
| 1 | Financials | 23.54% |
| 2 | Industrials | 12.21% |
| 3 | Technology | 9.83% |
| 4 | Energy | 9.71% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Hilton Worldwide
HLT
$64.2B
| $162K | 0.01% |
2,042
-300
| -13% | -$23.7K |
|
327
Netflix
NFLX
$512B
| $157K | 0.01% |
+400
| New | +$157K |
|
328
Thor Industries
THO
$5.59B
| $156K | 0.01% |
1,600
+400
| +33% | +$39K |
|
|
LOMA
329
Loma Negra
LOMA
$889M
| $155K | 0.01% |
15,130
-16,276
| -52% | -$167K |
|
|
BID
330
DELISTED
Sotheby's
BID
| $152K | 0.01% |
2,800
+500
| +22% | +$27.2K |
|
|
NVRO
331
DELISTED
NEVRO CORP.
NVRO
| $152K | 0.01% |
1,900
+200
| +12% | +$16K |
|
332
Fortune Brands Innovations
FBIN
$6.97B
| $150K | 0.01% |
3,276
| – | – |
|
333
JetBlue
JBLU
$1.84B
| $150K | 0.01% |
7,900
| – | – |
|
334
Edwards Lifesciences
EW
$44.3B
| $149K | 0.01% |
3,075
| – | – |
|
|
HRC
335
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $148K | 0.01% |
1,700
| – | – |
|
336
Vail Resorts
MTN
$5.55B
| $148K | 0.01% |
538
-200
| -27% | -$54.8K |
|
337
Bio-Rad Laboratories Class A
BIO
$7.64B
| $144K | 0.01% |
500
-100
| -17% | -$28.9K |
|
338
PJT Partners
PJT
$4.36B
| $138K | 0.01% |
2,593
| – | – |
|
339
Jazz Pharmaceuticals
JAZZ
$7.65B
| $138K | 0.01% |
800
+100
| +14% | +$17.2K |
|
340
Blackrock
BLK
$173B
| $137K | 0.01% |
274
-1,700
| -86% | -$848K |
|
341
Align Technology
ALGN
$9.55B
| $136K | 0.01% |
398
+100
| +34% | +$34.2K |
|
342
Unum
UNM
$12.6B
| $133K | 0.01% |
3,600
-38,777
| -92% | -$1.43M |
|
343
Service Corp International
SCI
$11.2B
| $132K | 0.01% |
+3,700
| New | +$132K |
|
344
Acushnet Holdings
GOLF
$4.38B
| $125K | 0.01% |
+5,100
| New | +$125K |
|
|
ABMD
345
DELISTED
Abiomed Inc
ABMD
| $123K | 0.01% |
300
-100
| -25% | -$40.9K |
|
346
Neurocrine Biosciences
NBIX
$13.9B
| $118K | 0.01% |
1,200
+100
| +9% | +$9.82K |
|
347
BioMarin Pharmaceuticals
BMRN
$10.3B
| $113K | 0.01% |
1,200
| – | – |
|
348
Northern Trust
NTRS
$24.6B
| $103K | 0.01% |
1,000
-600
| -38% | -$61.7K |
|
|
AGN
349
DELISTED
Allergan plc
AGN
| $100K | 0.01% |
+600
| New | +$100K |
|
350
Bank of New York Mellon
BK
$74.3B
| $93K | 0.01% |
1,724
-1,600
| -48% | -$86.3K |
|